Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

GLOBOSTAD

In this page

Clinical Trial

NCT03992417 Active, Not recruiting
GLOBOSTAD

A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis

Observational
Observational

Disease

Disease type

Keratoconus

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

11/06/2019

Closing date

31/03/2027

Inclusion criteria :

More

Exclusion criteria :

More

Funding

Private

Members involved

Others investigators

Pr Bart LEROY

Representative

Belgium

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Pr Elfride DE BAERE

Substitute

Belgium

Genetic Diagnostics (TWG6), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Pr Ingele Casteels

Representative

Belgium

See more

Pr Isabelle MEUNIER

Representative

France

Retinal Rare Eye Diseases (WG1)
See more

Pr Pierre FOURNIE

Representative

France

Anterior Segment Rare Eye Diseases (WG4), Registries & Epidemiology (TWG7), Research (TWG8)
See more

Dr João Pedro Marques

Substitute

Portugal

National Integration (TWG9), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

ERN EYE member investigating site

HCP : Principal investigators

Reference Center Rare Diseases ‘Genetic Sensory Diseases’, MAOLYA, Montpellier, France

Adress

Hôpital Gui de ChauliacService Ophtalmologie80, avenue Augustin Fliche 1er étage, bureau 1414

34 295 Montpellier Cedex 5

France

National Reference Center of Keratoconus (CRNK), CHU Toulouse, France

Adress

Service d'Ophtalmologie Pavillon Dieulafoy Place du Docteur BaylacTSA 40031

31000 Toulouse

France